Search Results - "Ankunda, Rogers"

Loss to follow-up and associated maternal factors among HIV-exposed infants at the Mbarara Regional Referral Hospital, Uganda: a retrospective study by Ankunda, Rogers, Cumber, Samuel Nambile, Atuhaire, Catherine, Kabanda, Taseera, Nkfusai, Claude Ngwayu, Wirsiy, Frankline Sevidzem, Turyakira, Eleanor

“…Loss to follow-up (LTFU) deprives HIV-exposed infants the lifesaving care required and results in exposing HIV free infants to virus requisition risk. We aimed…”
Get full text

Association between metabolic syndrome and cervical cancer among women in Southwestern Uganda: A case-control study by Kajabwangu, Rogers, Ngonzi, Joseph, Izudi, Jonathan, Bazira, Joel, Ssedyabane, Frank, Kanyesigye, Michael, Atwine, Raymond, Kayondo, Musa, Ankunda, Rogers, Lugobe, Henry Mark, Turanzomwe, Stuart, Randall, Thomas C., Bajunirwe, Francis

“…•Metabolic syndrome increases the risk of cervical cancer.•On their own, individual components of metabolic syndrome do not increase the risk of cervical…”
Get full text

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial by Jacobs, Tom G, Mumbiro, Vivian, Cassia, Uneisse, Zimba, Kevin, Nalwanga, Damalie, Ballesteros, Alvaro, Domínguez-Rodríguez, Sara, Tagarro, Alfredo, Madrid, Lola, Mutata, Constantine, Chitsamatanga, Moses, Bwakura-Dangarembizi, Mutsa, Passanduca, Alfeu, Buck, W Chris, Nduna, Bwendo, Chabala, Chishala, Najjingo, Elizabeth, Musiime, Victor, Moraleda, Cinta, Colbers, Angela, Mujuru, Hilda A, Rojo, Pablo, Burger, David M

“…Abstract Background We evaluated dolutegravir pharmacokinetics in infants with human immunodeficiency virus (HIV) receiving dolutegravir twice daily (BID) with…”
Get full text

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing by Moore, Cecilia L, Turkova, Anna, Mujuru, Hilda, Kekitiinwa, Adeodata, Lugemwa, Abbas, Kityo, Cissy M, Barlow-Mosha, Linda N, Cressey, Tim R, Violari, Avy, Variava, Ebrahim, Cotton, Mark F, Archary, Moherndran, Compagnucci, Alexandra, Puthanakit, Thanyawee, Behuhuma, Osee, Saϊdi, Yacine, Hakim, James, Amuge, Pauline, Atwine, Lorna, Musiime, Victor, Burger, David M, Shakeshaft, Clare, Giaquinto, Carlo, Rojo, Pablo, Gibb, Diana M, Ford, Deborah

“…Dolutegravir (DTG)-based antiretroviral therapy (ART) is highly effective and well-tolerated in adults and is rapidly being adopted globally. We describe the…”
Get full text

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial by Turkova, Anna, Waalewijn, Hylke, Chan, Man K, Bollen, Pauline D J, Bwakura-Dangarembizi, Mutsa F, Kekitiinwa, Adeodata R, Cotton, Mark F, Lugemwa, Abbas, Variava, Ebrahim, Ahimbisibwe, Grace Miriam, Srirompotong, Ussanee, Mumbiro, Vivian, Amuge, Pauline, Zuidewind, Peter, Ali, Shabinah, Kityo, Cissy M, Archary, Moherndran, Ferrand, Rashida A, Violari, Avy, Gibb, Diana M, Burger, David M, Ford, Deborah, Colbers, Angela

“…Children with HIV-associated tuberculosis (TB) have few antiretroviral therapy (ART) options. We aimed to evaluate the safety and pharmacokinetics of…”
Get full text

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial by Amuge, Pauline, Lugemwa, Abbas, Wynne, Ben, Mujuru, Hilda A, Violari, Avy, Kityo, Cissy M, Archary, Moherndran, Variava, Ebrahim, White, Ellen, Turner, Rebecca M, Shakeshaft, Clare, Ali, Shabinah, Nathoo, Kusum J, Atwine, Lorna, Liberty, Afaaf, Bbuye, Dickson, Kaudha, Elizabeth, Mngqibisa, Rosie, Mosala, Modehei, Mumbiro, Vivian, Nanduudu, Annet, Ankunda, Rogers, Maseko, Lindiwe, Kekitiinwa, Adeodata R, Giaquinto, Carlo, Rojo, Pablo, Gibb, Diana M, Turkova, Anna, Ford, Deborah

“…Young children living with HIV have few treatment options. We aimed to assess the efficacy and safety of dolutegravir-based antiretroviral therapy (ART) in…”
Get full text

Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial by Waalewijn, Hylke, Wasmann, Roeland E, Bamford, Alasdair, Gibb, Diana M, McIlleron, Helen M, Colbers, Angela, Burger, David M, Denti, Paolo

“…Abstract We characterized population pharmacokinetics in 42 African children receiving once-daily 25 mg (14 to <20 kg) or 50 mg (>20 kg) dolutegravir…”
Get full text

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia by Chabala, Chishala, Jacobs, Tom G, Moraleda, Cinta, Ndaferankhande, John M, Mumbiro, Vivian, Passanduca, Alfeu, Namuziya, Natasha, Nalwanga, Damalie, Musiime, Victor, Ballesteros, Alvaro, Domínguez-Rodríguez, Sara, Chitsamatanga, Moses, Cassia, Uneisse, Nduna, Bwendo, Bramugy, Justina, Sacarlal, Jahit, Madrid, Lola, Nathoo, Kusum J, Colbers, Angela, Burger, David M, Mulenga, Veronica, Buck, W Chris, Mujuru, Hilda A, te Brake, Lindsey H M, Rojo, Pablo, Tagarro, Alfredo, Aarnoutse, Rob E

“…Abstract Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in…”
Get full text

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial by Turkova, Anna, White, Ellen, Kekitiinwa, Adeodata R, Mumbiro, Vivian, Kaudha, Elizabeth, Liberty, Afaaf, Ahimbisibwe, Grace Miriam, Moloantoa, Tumelo, Srirompotong, Ussanee, Mosia, Nozibusiso Rejoice, Puthanakit, Thanyawee, Kobbe, Robin, Fortuny, Clàudia, Kataike, Hajira, Bbuye, Dickson, Na-Rajsima, Sathaporn, Coelho, Alexandra, Lugemwa, Abbas, Bwakura-Dangarembizi, Mutsa F, Klein, Nigel, Mujuru, Hilda A, Kityo, Cissy, Cotton, Mark F, Ferrand, Rashida A, Giaquinto, Carlo, Rojo, Pablo, Violari, Avy, Gibb, Diana M, Ford, Deborah

“…Cohort studies in adults with HIV showed that dolutegravir was associated with neuropsychiatric adverse events and sleep problems, yet data are scarce in…”
Get more information

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial by Mallewa, Jane, Szubert, Alexander J, Mugyenyi, Peter, Baleeta, Keith, Etyang, Anthony, Warambwa, Colin, Kelly, Christine, Agutu, Clara, Nkomani, Sanele, Musiime, Victor, Pett, Sarah L, Prendergast, Andrew J, Gibb, Diana M, Walker, A Sarah, Berkley, James A, Kityo, Cissy, Musiime, Victor, Wavamunno, Priscilla, Nambi, Esther, Ocitti, Paul, Ndigendawani, Milly, Acen, Juliet, Mbonye, Andrew, Nambaziira, Florence, Kangah, Mary, Abongomera, George, Aciro, Irene, Philliam, Aleti, Arach, Beatrice, Adong, Claudia, Otto, Ben, Abwola, Mary, Ssennono, Fred, Namisi, Ronald, Kikyonkyo, Dickson, Mushahara, Furaha, Musiime, Alex, Sirikye, Sowal, Myalo, Sula, Lugemwa, Abbas, Kasozi, Mariam, Atwine, Lorna, Natuhurira, Ian, Katemba, Chrispus, Ankunda, Rogers, Tukwasibwe, Deogratious, Ayesiga, Lillian, Hakim, James, Chidziva, Ennie, Tinago, Gloria, Steamer, John, Warambwa, Colin, Vhembo, Sydney, Mlambo, Brian, Ndemera, Buxton, Willard, Marko, Matiza, Patience, Guti, Vongai, Etyang, Anthony, Agutu, Clara, Njuguna, Patricia, Etyang, Timothy, Kithunga, Jefwa, Said Maitha, Salma, Mutai, Robert, Lozi Lewa, Margaret, Fondo, Amos, Njogu, Anne, Mwakisha, Bryan, Sudoi, Allan, Wachira, Simon, Tanui, Michael, Ekiru, Wilson, Mengich, Cecilia, Choge, Julie, Njenga, Kennedy, Anyango Orido, Millicent, Omondi Lwande, Gerald, Rutto, Peter, Mudogo, Alice, Kutto, Irene, Jaika, Linda, Pierre, Mowlem, Mallewa, Jane, Kaunda, Symon, Van Oosterhout, Joep, Heydermann, Robert, Selemani, George, Banda, Peter, Msuku, Harrison, Manda, Yollam, Sheha, Irene, Bwanali, Joseph, Limbuni, Molly, Gibb, Diana M, Walker, Ann Sarah, Rajapakse, Chathurika, Van Looy, Nadine, Bernays, Sarah, Mupambireyi, Zivai

“…In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have a high risk of mortality during the first few months after starting…”
Get full text